CANADIAN MEDICAL ASSOCIATION JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2019-08-01 lucky9571

你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表:
很难中。。
投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。
原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。
CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj

mileo 2015-11-11 00:51:00 发表: 很难中。。
投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。
原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。
CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj

191 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2022-04-10 dingguodong204296

审稿速度:1.0 | 投稿命中率:25.0
经验分享：cmaj我发过好几篇 clinical image

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2021-12-28 Mia

俢回包括几个方面？

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

什么叫俢回？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2020-08-01 ms6000001610724800

加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。

137 0

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2020-08-01 ms6000001610724800

加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。

170 0

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2020-02-06 146f6ef6m90(暂无昵称)

同问！lucky 2019-08-01 00:00:00 发表:
你投的另一个7分左右杂志是哪个呀

lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀

161 0

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2019-01-17 ms9574107592528786

审稿速度:6.0 | 投稿命中率:25.0
经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！

146 0

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2016-02-06 BetterJenny

审稿速度:1.0
经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials.
之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。
现在准备投6分的了，希望能中吧。
其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。

343 0

[GetPortalCommentsPageByObjectIdResponse(id=574286, encodeId=aecc5e4286ed, content=你投的另一个7分左右杂志是哪个呀mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=mileo 2015-11-11 00:51:00 发表: 很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIV2wGkGic0BZt626zvvYxwMMHMCBZY7C1fICJGvtoGAjxKqSpjWdFIIeAfLQ3jgNgTdIm4RXT9h3w/132, createdBy=f5ad2332186, createdName=lucky9571, createdTime=Thu Aug 01 00:00:00 CST 2019, time=2019-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210086, encodeId=c8a71210086ab, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：cmaj我发过好几篇 clinical image, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/16/a075e005deef5efb319dec1f1aa57eed.jpg, createdBy=f76a1589513, createdName=dingguodong204296, createdTime=Sun Apr 10 18:26:09 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088370, encodeId=130510883e0d1, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088369, encodeId=498710883698e, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805507, encodeId=7c9d80550e47, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美临床指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇中一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:58:19 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805506, encodeId=4cc6805506a7, content=加拿大皇家医学会院刊，仅次于bmj，很难，非常难，很少收基础研究偏临床，专家约稿，顶级期刊，主要是发北美指南或者团体作者序列研究，或者修改基础理论参数指标的文章，看看还行，投就算了，国人录取率不到百分之一，投了五篇只中了一篇。每年发文量奇低，不到两百篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f2199764, createdName=ms6000001610724800, createdTime=Sat Aug 01 08:56:47 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584313, encodeId=5ab7584313fa, content=同问！lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, beContent=lucky 2019-08-01 00:00:00 发表: 你投的另一个7分左右杂志是哪个呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849316, encodeId=afa1849316af, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然分没有之前那么高了，仍然还是内科非常好的一个期刊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Thu Jan 17 17:53:41 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519081, encodeId=13d15190810b, content=审稿速度:1.0 经验分享：CMAJ showcases innovative research and ideas aimed at improving health for people in Canada and globally. It publishes original clinical research, analyses and reviews, news, practice updates and thought-provoking editorials. 之前有的人说不收中国的，但是人家说的很清楚，应该是全球都收的。前几天发了一篇，3天之内就直接被拒了。速度也是良心。 现在准备投6分的了，希望能中吧。 其实讲真的，CMAJ的因子分是逐年下降啊，投的慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85891638859, createdName=BetterJenny, createdTime=Sat Feb 06 10:32:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516706, encodeId=1e34516e0659, content=很难中。。 投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。 原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。 CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Wed Nov 11 00:51:00 CST 2015, time=2015-11-11, status=1, ipAttribution=)]

2015-11-11 mileo

很难中。。
投了一篇，20天回来，reviewers意见不多而且建议接收，但是编辑说不太合适它的读者，拒了。。
原封不动地改投另一个因子7左右的杂志，两个月左右小修被接收了。
CMAJ 很苛刻，接受率不到5%，但是因子逐年下降。。还真不建议投cmaj

379 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务